Here are five things to know from the report.
1. The GI/endoscopy market includes:
• GI endoscopes
• Capsule endoscopes
• Stenting devices
• Dilation devices
• ERCP devices
• Biopsy forceps
• Polypectomy snares
• Hemostasis devices
• Enteral feeding devices
2. By 2020, approximately 75 million GI endoscopic procedures will be performed in the United States and Europe combined. Colorectal cancer screening is the most common GI/endoscopy procedure, followed by procedures such as removal of GI tract abnormalities and placement of enteral feeding tubes.
3. Technological advancements play a key role in the growth of the GI endoscope market. The market for GI endoscope technology is expected to reach a value of $1.7 billion by 2020.
4. Reimbursement cuts and commoditization are two additional forces driving the GI/endoscopy market. Reimbursement cuts limit the growth of GI procedure numbers, especially low-paying procedures such as colonoscopy, according to the report. Items such as polypectomy snares and biopsy forceps are predicted to have a lack of technological advancement. Competition for the sale of these items will be focused on price.
5. Leading companies in the U.S. and European market include:
• Olympus
• Boston Scientific
• Pentax
• FUJIFILM Medical Systems
• Cook Medical
• Kimberly-Clark/Vygon
• Fresenius Kabi
• Covidien
More articles on gastroenterology:
UPMC GI scope infection research could alter national guidelines
How to boost efficiency without sacrificing quality in GI
Colorectal cancer screening in 2015: Achievements to date & hurdles ahead
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.